News

Picture a living cell as if it were a city. If you were the urban planner for this (very little, very alive) city, one of the ...
Picture a living cell as if it were a city. If you were the urban planner for this (very little, very alive) city, one of the ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
Machine learning enabled this breakthrough by accelerating high-performance battery material discovery.